搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Escherichia coli O81 50S ribosomal protein L24 (rplX) CSB-YP484525EOP
CSB-EP484525EOP
CSB-BP484525EOP
CSB-MP484525EOP
CSB-EP484525EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 50S ribosomal protein L4 (rplD) CSB-YP484526EOP
CSB-EP484526EOP
CSB-BP484526EOP
CSB-MP484526EOP
CSB-EP484526EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Glyoxylate/hydroxypyruvate reductase B (ghrB) CSB-YP484527EOP
CSB-EP484527EOP
CSB-BP484527EOP
CSB-MP484527EOP
CSB-EP484527EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 C4-dicarboxylate transport protein (dctA), partial CSB-YP484528EOP
CSB-EP484528EOP
CSB-BP484528EOP
CSB-MP484528EOP
CSB-EP484528EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 tRNA modification GTPase MnmE (mnmE) CSB-YP484529EOP
CSB-EP484529EOP
CSB-BP484529EOP
CSB-MP484529EOP
CSB-EP484529EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 L-lactate dehydrogenase [cytochrome] (lldD) CSB-YP484530EOP
CSB-EP484530EOP
CSB-BP484530EOP
CSB-MP484530EOP
CSB-EP484530EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 50S ribosomal protein L33 (rpmG) CSB-YP484531EOP
CSB-EP484531EOP
CSB-BP484531EOP
CSB-MP484531EOP
CSB-EP484531EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Protein CyaY (cyaY) CSB-YP484532EOP
CSB-EP484532EOP
CSB-BP484532EOP
CSB-MP484532EOP
CSB-EP484532EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Probable ubiquinone biosynthesis protein UbiB (ubiB), partial CSB-YP484533EOP1
CSB-EP484533EOP1
CSB-BP484533EOP1
CSB-MP484533EOP1
CSB-EP484533EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Der GTPase-activating protein YihI (yihI) CSB-YP484534EOP
CSB-EP484534EOP
CSB-BP484534EOP
CSB-MP484534EOP
CSB-EP484534EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 D-ribose pyranase (rbsD) CSB-YP484535EOP
CSB-EP484535EOP
CSB-BP484535EOP
CSB-MP484535EOP
CSB-EP484535EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 D-tyrosyl-tRNA (Tyr) deacylase CSB-YP484536EOP
CSB-EP484536EOP
CSB-BP484536EOP
CSB-MP484536EOP
CSB-EP484536EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 L-rhamnose-proton symporter (rhaT), partial CSB-YP484537EOP
CSB-EP484537EOP
CSB-BP484537EOP
CSB-MP484537EOP
CSB-EP484537EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP484538EOP
CSB-EP484538EOP
CSB-BP484538EOP
CSB-MP484538EOP
CSB-EP484538EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Trp operon repressor (trpR) CSB-YP484539EOP
CSB-EP484539EOP
CSB-BP484539EOP
CSB-MP484539EOP
CSB-EP484539EOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O81 Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA), partial CSB-YP484540EOP1
CSB-EP484540EOP1
CSB-BP484540EOP1
CSB-MP484540EOP1
CSB-EP484540EOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Alkanesulfonate monooxygenase (ssuD) CSB-YP484541EOG
CSB-EP484541EOG
CSB-BP484541EOG
CSB-MP484541EOG
CSB-EP484541EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Chaperone protein TorD (torD) CSB-YP484542EOG
CSB-EP484542EOG
CSB-BP484542EOG
CSB-MP484542EOG
CSB-EP484542EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Putative aminoacrylate peracid reductase RutC (rutC) CSB-YP484543EOG
CSB-EP484543EOG
CSB-BP484543EOG
CSB-MP484543EOG
CSB-EP484543EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O17:K52:H18 Anti-adapter protein iraM (iraM) CSB-YP484544EOG
CSB-EP484544EOG
CSB-BP484544EOG
CSB-MP484544EOG
CSB-EP484544EOG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>